Document:

20-F

Exhibit 4.13  

Summary Translation
(from Hebrew) 

Employment agreement
by and between 

Crow Electronic Engineering Ltd. (Orev) and Mrs. Monique Bennoun-Melman 

	1.  	The
agreement is effective as of August 1, 2004 (effective date) and shall
               remain effective for a term of twelve months commencing the effective date
and                ending on July 31, 2005 and shall be automatically renewed for further
periods                of 12 months each, unless a prior written notice of at least 60
days is                furnished by either of the parties or unless terminated earlier as
provided                below. 

	2.  	Either
party may terminate the agreement for any reason by providing the other
               party with a prior written notice of two months. However, Orev may
terminate the                agreement with immediate effect without prior notice, under
the following                circumstances: 

	 	2.1. 	a
breach of the agreement by Mrs. Bennoun-Melman which has not been remedied
               within thirty days from written notice thereof. 

	 	2.2. 	final
conviction of Mrs. Bennoun-Melman for a felony having moral turpitude
               which, in the opinion of the board of directors of Orev, does not allow
for the                continuation of his employment with Orev. 

	 	2.3. 	An
order for insolvency has been delivered against Mrs. Bennoun-Melman, or she
               has been declared bankrupt and such orders or declarations have not been
               dismissed within ninety days and such orders, in the opinion of the board
of                directors of Orev, may not permit for the continuation of Mrs.
               Bennoun-Melman’s employment with Orev. 

	 	2.4. 	In
the event of incompetence of Mrs. Bennoun-Melman to perform any legal
               function and/or unfitness by law, or inability to, temporarily or
permanently,                care for her business. 

	 	2.5. 	In
the event of a beach of loyalty or duty of care to Orev or acting with
               conflict of interest with the interests of Orev. 

	 	2.6. 	If
the acts or omissions of Mrs. Bennoun-Melman caused maliciously real damage
               to Orev, or upon other circumstances by law that permit denouncement of
payment                of severance pay upon termination. 

	3.  	Mrs.
Bennoun-Melman shall serve as Orev’s Sales and Marketing Director,
               subject to the directions of the CEO of Orev. 

	4.  	As
consideration for the performance of his functions under the agreement, Mrs.
               Bennoun-Melman shall receive from Orev, as of the effective date, a gross
               monthly salary of NIS 25,000. In addition, as special consideration and
               incentive for Mrs. Bennoun-Melman’s undertaking to refrain from
competing                with the business of Orev, as described below, Mrs.
Bennoun-Melman shall be                entitled, during the term of the agreement, to an
annual incentive based on                Orev’s audited annual financial reports
which shall be equal to 0.75% of                Orev’s unconsolidated annual sales
in each calendar year exceeding US$ 24                million. Payment of the special
consideration shall be made within 30 days from                the date of approval by
the board of directors of Orev of the annual audited                financial reports for
any relevant year. In the event of termination of the                agreement during any
calendar year, the special consideration shall be                calculated pro rata to
the term of actual employment of Mrs. Bennoun-Melman. 

	5.  	In
addition, Mrs. Bennoun-Melman shall be entitled to maintenance of private
               car, cellular phone, annual vacation of 22 days, contribution to
management                insurance and advance education fund (Keren Hishtalmut). 

	6.  	Mrs.
Bennoun-Melman undertook to keep any information concerning Orev
               confidential and further to refrain from competing, directly or
indirectly,                during the term of her employment agreement with Orev and for
a further period                of 12 months thereafter, with the business of Orev and
its affiliates. In the                event of a breach by Mr. Melman of his undertaking
for non-competition, Mrs.                Bennoun-Melman shall return the special
consideration as described in Section 4                above received from Orev during
the previous five years, linked to the Israeli                CPI including an annual
interest at the rate of 4%. 

	7.  	The
agreement is subject to the required approvals of the organs of Orev,
               according to the Companies Law, 1999.Fourth Amendment to the Employment Agreement

 Exhibit 10.32 
  
 FOURTH AMENDMENT TO EMPLOYMENT AGREEMENT 
  
 This FOURTH AMENDMENT TO EMPLOYMENT AGREEMENT, dated as of March 7, 2005 (this “Amendment”), to THE
EMPLOYMENT AGREEMENT, dated as of May 24, 2001 (the “Agreement”), as amended as of December 1, 2001, as of July 1, 2003, and as of March 10, 2004 (as amended, the “Agreement”), by and between KORN/FERRY INTERNATIONAL, a
Delaware corporation with its principal offices in Los Angeles, California (the “Company”), and PAUL C. REILLY, an individual (the “Executive”). 
  
 RECITALS 
  
 WHEREAS, the Company and Executive desire to amend the Agreement to account for Executive’s participation in the Company’s Executive
Capital Accumulation Plan; and 
  
 WHEREAS, in light of the
foregoing, the Company and Executive desire to amend the Agreement as set forth herein. 
  
 AMENDMENT 
  
 NOW
THEREFORE, in consideration of the foregoing premises and the mutual covenants contained herein, and other good and valuable consideration the receipt and sufficiency of which is hereby acknowledged, it is mutually agreed to by the parties as
follows: 
  
 A.    Amendment to Certain
Termination Provisions. 
  
 1. Section 8(a)
of the Agreement is hereby amended and restated to read in its entirety as follows: 
  
 (a) Death. 
  
 If Executive’s employment with the Company terminates before the end of the term by reason of Executive’s death, then as soon as
practicable thereafter the Company will pay to Executive’s estate an amount equal to Executive’s “Accrued Compensation” (as defined in Section 8(h)), and all outstanding stock options and other equity-type incentives held
by Executive and all of Executive’s benefits under the Executive Capital Accumulation Plan at the time of Executive’s death will become fully vested (whether or not fully vested immediately prior to Executive’s death) and shall remain
exercisable until their originally scheduled expiration dates. Executive’s covered dependent(s) will be entitled to continue to participate at the expense of the Company in the Company’s group health plan(s) after Executive’s death at
the same benefit level and to the same extent and for the same contribution, if any, as such continued participation is available to other executive officers of the Company, and such participation may continue for such additional period as may be
available under COBRA. 
  
 2. Section 8(b) is hereby
amended and restated to read in its entirety as follows: 
  
 (b) Disability. 
  
 If the Company terminates Executive’s employment before the end of the term by reason of Executive’s Disability (as defined in Section 8(h)), then as soon as practicable thereafter the Company will pay to Executive an
amount equal to Executive’s Accrued Compensation, and all outstanding stock options and other equity-type incentives held by Executive and all of Executive’s benefits under the Executive Capital Accumulation Plan at Executive’s
termination date will become fully vested and shall remain exercisable until their originally scheduled expiration dates. Executive and Executive’s covered dependent(s) will be entitled to continue to participate at the expense of the Company
in the Company’s 

 
group health plan(s) after Executive’s termination at the same benefit level and to the same extent and for the same contribution, if any, as such
continued participation is available to other executive officers of the Company, and such participation may continue for such additional period as may be available under COBRA. 
  
 3. Section 8(d) is hereby amended and restated to read in its entirety as follows: 
  
 (d) Termination by the Company Without Cause, by
Executive for Good Reason or for Failure by the Company to Renew Agreement Prior to Change in Control. 
  
 If Executive’s employment is terminated prior to a “Change in Control” (as defined in Schedule A) (i) by the Company
without Cause, or (ii) by Executive for Good Reason, or (iii) by reason of the Company’s failure to renew this Agreement at any time before Executive reaches the age of 65, then (1) the Company shall pay to Executive within 30 days
Executive’s Accrued Compensation; (2) the Company shall pay to Executive within 30 days a lump sum payment equal to two times Executive’s then current Base Salary and target bonus provided, however, that if Executive’s employment is
terminated by reason of the Company’s failure to renew this Agreement, then Executive shall be entitled only to one times the then current Base Salary and target bonus; (3) Executive and Executive’s covered dependent(s) will be entitled to
continue to participate at the expense of the Company in the Company’s group health plan(s) after Executive’s termination at the same benefit level and to the same extent and for the same contribution, if any, as such continued
participation is available to other executive officers of the Company, and such participation may continue for a period of two years after such termination; provided, however, that if such termination is due to the Company’s failure to renew,
then the period of continued participation will only be for one year after such termination; and (4) all outstanding stock options and other equity-type incentives held by Executive and all of Executive’s benefits under the Executive Capital
Accumulation Plan at the time of Executive’s termination will become fully vested and shall remain exercisable until their originally scheduled expiration dates. 
  
 4. Section 8(e) is hereby amended and restated to read in its entirety as follows: 
  
 (e) Following a Change of Control, Termination by the
Company Without Cause or by Executive for Good Reason. 
  
 If a Change in Control occurs and, within 12 months after the date on which the Change in Control occurs, Executive’s employment is terminated (i) by the Company without Cause or (ii) by Executive for Good
Reason, or (iii) by reason of the Company’s failure to renew this Agreement at any time before Executive reaches the age of 65, then: (1) the Company shall pay to Executive within 30 days Executive’s Accrued Compensation; (2) the Company
shall pay to Executive within 30 days a lump sum payment equal to (A) two times the then current Base Salary or two times Executive’s annual base salary in effect just prior to the Change in Control, whichever amount is higher, plus (B) the
higher of two times the annual maximum cash bonus for Executive for the incentive year in which such termination occurs or two times the annual maximum cash bonus for Executive applicable to the fiscal year preceding the year in which such
termination occurs; (3) Executive and Executive’s covered dependent(s) will be entitled to continue to participate at the expense of the Company in the Company’s group health plan(s) after Executive’s termination at the same benefit
level and to the same extent and for the same contribution, if any, as such continued participation is available to other executive officers of the Company, and such participation may continue for a period of two years after such termination; and
(4) all outstanding stock options and other equity-type incentives held by Executive and all of Executive’s benefits under the Executive Capital Accumulation Plan at the time of Executive’s termination will become fully vested and shall
remain exercisable until their originally scheduled expiration dates. 
  
 B. No Other Modification.    Except as specifically modified herein, the remaining terms and provisions of the Agreement shall be and remain in full force and effect in accordance with their
terms. Any reference in the Agreement pertaining to any time from and after the effective date of this Amendment shall be deemed a reference to the Agreement as modified and amended hereby. 

 C. Entire Agreement.    This Amendment contains the
entire understanding and agreement between the parties concerning the subject matter hereof and supersedes all prior agreements, understandings, discussions, negotiations and undertakings, whether written or oral, between the parties with respect
thereto. 
  
 D.
Counterparts.    This Amendment may be executed in two or more counterparts with the same effect as if all parties had signed the same document. All such counterparts shall be deemed an original, shall be
construed together and shall constitute one and the same instrument. 
  
 IN WITNESS WHEREOF, the undersigned have executed this Amendment as of the date first above written. 
  

					
	 The Company:
	 	 KORN/FERRY INTERNATIONAL

			
	 	 	 By:
	 	 /s/    EDWARD D.
MILLER        

	 	 	 	 	EDWARD D. MILLER
			
	 Executive:
	 	 	 	 
			
	 	 	 	 	 /s/    PAUL C.
REILLY        

	 	 	 	 	PAUL C. REILLY

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00087-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00087-of-00352.parquet"}]]